Literature DB >> 3385533

Serum C-reactive protein in assessment of pulmonary exacerbations and antimicrobial therapy in cystic fibrosis.

S Glass1, C Hayward, J R Govan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3385533     DOI： 10.1016/s0022-3476(88)80533-x

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  4 in total

Review 1.  Microbiology of cystic fibrosis lung infections: themes and issues.

Authors:  J R Govan; J W Nelson
Journal:  J R Soc Med       Date:  1993       Impact factor: 5.344

2.  Specific decrease of anti-pseudomonal IgA after anti-pseudomonal therapy in cystic fibrosis.

Authors:  K de Boeck; E Eggermont; M Smet; P van Reempts; H P van Bever; W J Stevens
Journal:  Eur J Pediatr       Date:  1995-02       Impact factor: 3.183

3.  Procalcitonin predicts the severity of cystic fibrosis pulmonary exacerbations and readmissions in adult patients: a prospective cohort study.

Authors:  Kristina L Bailey; Peter J Murphy; Olena K Lineberry; Matthew R Haack; John D Dickinson; Andre C Kalil
Journal:  J Investig Med       Date:  2020-01-21       Impact factor: 2.895

4.  Clinical manifestations of exacerbations of cystic fibrosis associated with nonbacterial infections.

Authors:  C G Pribble; P G Black; J A Bosso; R B Turner
Journal:  J Pediatr       Date:  1990-08       Impact factor: 4.406
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.